Status:
UNKNOWN
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
Lead Sponsor:
Middle Tennessee Research Institute
Collaborating Sponsors:
American Society of Health-System Pharmacists Research and Education Foundation
Conditions:
Coronary Heart Disease
Myocardial Infarction
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
Existing trials for the patient with coronary heart disease evaluate the interdisciplinary team dynamic where pharmacists (pharmacotherapists) provide therapeutic recommendations in the inpatient envi...
Detailed Description
Existing trials for the patient with coronary heart disease evaluate the interdisciplinary team dynamic where pharmacists (pharmacotherapists) provide therapeutic recommendations in the inpatient envi...
Eligibility Criteria
Inclusion
- All patients with a diagnosis of ACS at the VA Tennessee Valley Healthcare System who
- are greater than or equal to 60 years of age
- will benefit from Medication Therapy Management (MTM):
- Have a baseline LDL \>79mg/dL in the first 24 hours of acute coronary syndrome (ACS) OR if LDL not assessed in the first 24 hours of ACS, have a recent LDL \>79mg/dL (in the last 15 months) OR not have an LDL assessed prior to or during admission.
- AND
- Have outpatient blood pressures (BP) above goal on 65% or more of assessments within the last 15 months or a SBP \>140mmHg or DBP\>90mmHg or both on the last outpatient BP assessment.
- are enrolled or will be enrolled in outpatient cardiovascular services at the VA Tennessee Valley Healthcare System
Exclusion
- Patients who
- are transferred to a long-term care facility or skilled nursing facility
- are assigned to another Veterans Health Administration medical center,
- have a discharge primary or secondary discharge diagnosis code for dementia, schizophrenia, or organic brain syndrome,
- cannot speak or understand English or give written informed consent,
- are enrolled in hospice or palliative care
- are participating in another trial that prohibits participation in this trial
- have a baseline LDL\> 200mg/dL in proximity to admission suggestive of familial hypercholesterolemia (FH) or a known diagnosis of FH
- require clonidine or minoxidil for blood pressure control prior to the index admission
- are enrolled in the Nashville preventative cardiovascular clinic for hypertension
- have a urinary drug screen positive for cocaine in the last 12 months
- have plans to move in the next 6 months
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01427218
Start Date
November 1 2010
End Date
December 1 2012
Last Update
September 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Tennessee Valley Healthcare System
Nashville, Tennessee, United States, 37212